ArticleInternational journal of women's health2025
Electroacupuncture for Refractory Chronic Pelvic Pain: A Case Report with 24-Month Follow-Up.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic pelvic pain (CPP) is a common condition involving multiple systems, characterized by complex manifestations and diverse clinical symptoms. The current treatment options for CPP are limited and may be only effective for some patients with identifiable etiologies. This paper aims to report a woman with refractory CPP who experienced significant improvement in pain and quality of life following electroacupuncture (EA) treatment. Case Summary: A 28-year-old woman experienced abdominal pain (Numeric Rating Scale [NRS] score of 6-7) after a medical abortion and intense exercise. Despite treatment with leuprolide acetate and pregabalin, her pain persisted (NRS score of 7-8). In January 2022, she was diagnosed with CPP and underwent superior hypogastric plexus neurolysis. Postoperatively, she experienced severe pain exacerbation (NRS score of 10). Traditional Chinese medicine and acupuncture provided little relief. After 40 sessions of EA treatment, the patient experienced significant relief in pain (from 10 to 2 in the worst NRS score and from 8 to 1 in the average NRS score), and there was also notable improvements in her quality of life and overall health status (from 0.331 to 0.942 in five-level EuroQol five-dimensional questionnaire [EQ-5D-5L] index and from 20 to 80 in the EQ visual analogue scale [EQ VAS]). Conclusion: EA may be a complementary and alternative therapy for CPP women, particularly when other treatments failed. Additionally, EA may offer potential long-term relief for CPP patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.